Skip to main content

Peer Review reports

From: Secondary endpoints analysis in patients with estrogen receptor-positive metastatic breast cancer treated with everolimus and exemestane enrolled in Oral Care-BC

Original Submission
12 Dec 2019 Submitted Original manuscript
27 Dec 2019 Author responded Author comments - katsuhiko nakatsukasa
Resubmission - Version 2
27 Dec 2019 Submitted Manuscript version 2
16 Jul 2020 Author responded Author comments - katsuhiko nakatsukasa
23 Feb 2020 Reviewed Reviewer Report - Antonino Musolino
24 Feb 2020 Reviewed Reviewer Report - Mariangela Ciccarese
25 Jun 2020 Reviewed Reviewer Report - Research Square Reviewer 1
Resubmission - Version 3
16 Jul 2020 Submitted Manuscript version 3
10 Dec 2020 Author responded Author comments - katsuhiko nakatsukasa
17 Jul 2020 Reviewed Reviewer Report - Antonino Musolino
21 Jul 2020 Reviewed Reviewer Report - Research Square Reviewer 1
17 Nov 2020 Reviewed Reviewer Report - Research Square Reviewer 2
Resubmission - Version 4
10 Dec 2020 Submitted Manuscript version 4
Publishing
16 Dec 2020 Editorially accepted
7 Jan 2021 Article published 10.1186/s12885-020-07746-9

You can find further information about peer review here.

Back to article page